Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Honoring the career and research accomplishments of Frances E. Allen, the 2006 recipient of the A.M. Turing Award.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.Con.Res 95 - Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043 - Labor-HHS Education Appropriations S.Con.Res.70 - Fiscal 2009 Senate Budget Resolution
Honoring the career and research accomplishments of Frances E. Allen, the 2006 recipient of the A.M. Turing Award.
Client: CEPHALON INC · Firm: CEPHALON, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CEPHALON INC via CEPHALON, INC.
2008 · second_quarter · Q2
H.Con.Res 95 - Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043 - Labor-HHS Education Appropriations S.Con.Res.70 - Fiscal 2009 Senate Budget Resolution
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food & Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
Source: Senate LDA
H.Con.Res 95 - Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043 - Labor-HHS Education Appropriations S.Con.Res.70 - Fiscal 2009 Senate Budget Resolution
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food & Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food and Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: CEPHALON INC · Firm: CEPHALON, INC.
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food and Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: CEPHALON INC · Firm: CEPHALON, INC.
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food & Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food & Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food and Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food and Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food & Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.Con.Res 95 - Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043 - Labor-HHS Education Appropriations S.Con.Res.70 - Fiscal 2009 Senate Budget Resolution
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.Con.Res 95 - Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043 - Labor-HHS Education Appropriations S.Con.Res.70 - Fiscal 2009 Senate Budget Resolution
To require cigarette products to be placed under or behind the counter in retail sales.
Client: CEPHALON INC · Firm: CEPHALON, INC.
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food and Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
To require cigarette products to be placed under or behind the counter in retail sales.
Client: CEPHALON INC · Firm: CEPHALON, INC.
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food & Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
Honoring the career and research accomplishments of Frances E. Allen, the 2006 recipient of the A.M. Turing Award.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.Con.Res 95. Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043, Labor-HHS Education Appropriations
Honoring the career and research accomplishments of Frances E. Allen, the 2006 recipient of the A.M. Turing Award.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.Con.Res 95. Support for additional FDA resources. Support for funds for SAMHSA.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: CEPHALON INC · Firm: CEPHALON, INC.
P.L. 109-57, implementation of export regulations for controlled substances S.3807, Senators Enzy, Kennedy, Drug Safety legislation, "Enhancing Drug Safety & Innovation Act of 2006." Section 1. riskmaps; section 4. Advisory committees; approval standards for pharmaceuticals. H.R. 3162 SCIP; H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: CEPHALON INC · Firm: CEPHALON, INC.
P.L. 109-57, implementation of export regulations for controlled substances. S. 3807, Sens Enzy, Kennedy, Drug Safety legislation, "Enhancing Drug Safety and Innovation Act of 2006." Section 1. riskmaps; section 4. Advisory committees; approval standards for pharmaceuticals. H.R. 3162 SCHIP; H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007
To extend the temporary suspension of duty on 2-Chloro benzyl chloride.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
To extend the temporary suspension of duty on 2-Chloro benzyl chloride.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
P.L. 109-57, implementation of export regulations for controlled substances. S. 3807, Sens Enzy, Kennedy, Drug Safety legislation, "Enhancing Drug Safety and Innovation Act of 2006." Section 1. riskmaps; section 4. Advisory committees; approval standards for pharmaceuticals. H.R. 3162 SCHIP; H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007
P.L. 109-57, implementation of export regulations for controlled substances S.3807, Senators Enzy, Kennedy, Drug Safety legislation, "Enhancing Drug Safety & Innovation Act of 2006." Section 1. riskmaps; section 4. Advisory committees; approval standards for pharmaceuticals. H.R. 3162 SCIP; H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007.
To suspend temporarily the duty on Procion Yellow H-EXL.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
To suspend temporarily the duty on Procion Yellow H-EXL.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: CEPHALON INC · Firm: CEPHALON, INC.
H.Con.Res 95. Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043, Labor-HHS Education Appropriations
To require cigarette products to be placed under or behind the counter in retail sales.
Client: CEPHALON INC · Firm: CEPHALON, INC.
P.L. 109-57, implementation of export regulations for controlled substances. S. 3807, Sens Enzy, Kennedy, Drug Safety legislation, "Enhancing Drug Safety and Innovation Act of 2006." Section 1. riskmaps; section 4. Advisory committees; approval standards for pharmaceuticals. H.R. 3162 SCHIP; H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007
To require cigarette products to be placed under or behind the counter in retail sales.
Client: CEPHALON INC · Firm: CEPHALON, INC.
P.L. 109-57, implementation of export regulations for controlled substances S.3807, Senators Enzy, Kennedy, Drug Safety legislation, "Enhancing Drug Safety & Innovation Act of 2006." Section 1. riskmaps; section 4. Advisory committees; approval standards for pharmaceuticals. H.R. 3162 SCIP; H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007.
Brazillian intellectual property issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institute on Alcohol Abuse & Alcoholism (NIAA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
CEPHALON INC via CEPHALON, INC.
2008 · first_quarter · Q1
Brazilian intellectual property issues
H.Con.Res 95 - Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043 - Labor-HHS Education Appropriations S.Con.Res.70 - Fiscal 2009 Senate Budget Resolution
S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food and Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA)
CEPHALON INC via CEPHALON, INC.
2007 · year_end · YY
Support for standards for new pharmaceuticals therapies for the treatment of alcoholism. Mental Health Parity
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
Brazilian intellectual property issues
H.Con.Res 95. Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043, Labor-HHS Education Appropriations
P.L. 109-57, implementation of export regulations for controlled substances S.3807, Senators Enzy, Kennedy, Drug Safety legislation, "Enhancing Drug Safety & Innovation Act of 2006." Section 1. riskmaps; section 4. Advisory committees; approval standards for pharmaceuticals. H.R. 3162 SCIP; H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA)
CEPHALON INC via CEPHALON, INC.
2007 · mid_year · MM
P.L. 109-57, implementation of export regulations for controlled substances. S. 3807, Sens Enzy, Kennedy, Drug Safety legislation, "Enhancing Drug Safety and Innovation Act of 2006." Section 1. riskmaps; section 4. Advisory committees; approval standards for pharmaceuticals. H.R. 3162 SCHIP; H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007
H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.
Support for standards for new pharmaceuticals therapies for the treatment of alcoholism.
H.Con.Res 95. Support for additional FDA resources. Support for funds for SAMHSA.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)